quinazolines has been researched along with isatin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E; Nath, G; Pandeya, SN; Sriram, D | 1 |
| Al-Dhfyan, A; Alanazi, FK; Radwan, AA | 1 |
| Arewång, CJ; Bergman, J; Svensson, PH | 1 |
| Abdel-Aziz, HA; Abou-Seri, SM; Aly, MH; Eldehna, WM; Fares, M; Tolba, MF | 1 |
| Abdel-Aziz, AA; Abou-Zeid, LA; Al-Dhfyan, A; Al-Gendy, MA; Al-Obaid, AM; Alkahtani, HM; El-Azab, AS | 1 |
| Ahmed, HEA; Almehmadi, MA; Aouad, MR; Ihmaid, S; Omar, AM; Rezki, N; Shehata, AM | 1 |
6 other study(ies) available for quinazolines and isatin
| Article | Year |
|---|---|
Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antifungal Agents; Bacteria; Isatin; Mannich Bases; Quinazolines; Schiff Bases | 1999 |
Synthesis, and docking studies of some fused-quinazolines and quinazolines carrying biological active isatin moiety as cell-cycle inhibitors of breast cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Female; Humans; Inhibitory Concentration 50; Isatin; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Quinazolines; Structure-Activity Relationship | 2013 |
Oxidative ring expansion of spirocyclic oxindole derivatives.
Topics: Crystallography, X-Ray; Indoles; Isatin; Molecular Structure; ortho-Aminobenzoates; Oxidation-Reduction; Oxindoles; Quinazolines; Quinazolinones; Spiro Compounds | 2014 |
Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Hep G2 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; Isatin; MCF-7 Cells; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Signal Transduction; Structure-Activity Relationship | 2015 |
Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Isatin; Molecular Docking Simulation; Molecular Structure; Quinazolines; Structure-Activity Relationship | 2017 |
Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses.
Topics: Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Isatin; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship; Triazoles | 2020 |